Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

Shaping the future of oncology treatment

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

New analysis compares emerging algorithms that look for cancer mutations

New analysis compares emerging algorithms that look for cancer mutations

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Adding new antibody to chemotherapy could bolster effects of cancer treatment

New findings highlight possibility of developing specific cancer drugs with fewer side effects

New findings highlight possibility of developing specific cancer drugs with fewer side effects

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Cancer drug may help treat food allergies

Cancer drug may help treat food allergies

WHO to launch pilot project for prequalifying biosimilar cancer medicines

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists announce ‘outstanding’ results of new blood cancer study

Study explains how genetic mutations linked to telomere capping complex contribute to cancers

Study explains how genetic mutations linked to telomere capping complex contribute to cancers

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Study reveals novel mutations in mucosal melanoma that may pave way for new therapies

Study reveals novel mutations in mucosal melanoma that may pave way for new therapies

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer